rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1987-6-9
|
pubmed:abstractText |
Outcomes were compared between consecutive patients who had received either total lymphoid irradiation (TLI) or immunosuppressant treatment for intractable rheumatoid arthritis (RA). There were 33 TLI and 32 immunosuppressive recipients; all patients had failed standard therapy. Average followup from the start of therapy was 2.7 years for TLI and 5.9 years for immunosuppressive recipients. Final disability levels were the same in both groups; mortality was equal in both groups as well. There were more hospitalizations for infections in the TLI group and the infecting organisms tended to be staphylococcus or gram negative organisms. Apart from infections, there were more adverse effects reported in the immunosuppressive therapy group.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
46-51
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3572934-Arthritis, Rheumatoid,
pubmed-meshheading:3572934-Azathioprine,
pubmed-meshheading:3572934-Chlorambucil,
pubmed-meshheading:3572934-Cyclophosphamide,
pubmed-meshheading:3572934-Female,
pubmed-meshheading:3572934-Follow-Up Studies,
pubmed-meshheading:3572934-Gastrointestinal Diseases,
pubmed-meshheading:3572934-Humans,
pubmed-meshheading:3572934-Immune Tolerance,
pubmed-meshheading:3572934-Immunosuppressive Agents,
pubmed-meshheading:3572934-Infection,
pubmed-meshheading:3572934-Lymphoid Tissue,
pubmed-meshheading:3572934-Male,
pubmed-meshheading:3572934-Methotrexate,
pubmed-meshheading:3572934-Middle Aged,
pubmed-meshheading:3572934-Radiotherapy
|
pubmed:year |
1987
|
pubmed:articleTitle |
Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|